Zhou Yuanzhi, Wei Chengyan, Xu Yuqi, Wang Jingjing, Zhang Chunwei, Jin Yong
School of Pharmacy, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei, 230032, China.
Curr Cancer Drug Targets. 2024 Aug 6. doi: 10.2174/0115680096323472240710101854.
Colorectal cancer (CRC) is currently the third most common malignancy world-wide, with an increasing mortality rate and treatment resistance. Due to the lack of effective biomarkers and therapeutic targets, the early diagnosis and treatment of colorectal cancer re-main suboptimal. Circular RNAs (circRNAs) are a novel class of non-coding RNAs with co-valent closed-loop structures that are well stabilized and conserved and are involved in multi-ple pathological conditions in humans. CircRNAs have been identified to be enriched and sta-ble in exosomes. In addition, there is growing proof that exosomal circRNAs that have been identified as oncogenes or tumor suppressors regulate CRC growth, migration, and sensitivity to radiotherapy and chemotherapy. Exosomal circRNAs represent promising candidates as di-agnostic biomarkers and anti-tumor targets. In this article, we explore recent studies on exo-somal circRNAs in CRC and describe their biological functions in colorectal cancer develop-ment, illustrating their potential as biomarkers and targeted therapeutic capabilities.
结直肠癌(CRC)是目前全球第三大常见恶性肿瘤,其死亡率和治疗耐药性呈上升趋势。由于缺乏有效的生物标志物和治疗靶点,结直肠癌的早期诊断和治疗仍不尽人意。环状RNA(circRNAs)是一类新型的非编码RNA,具有共价闭环结构,稳定性和保守性良好,参与人类多种病理状况。已发现circRNAs在外泌体中富集且稳定。此外,越来越多的证据表明,已被鉴定为癌基因或肿瘤抑制因子的外泌体circRNAs可调节结直肠癌的生长、迁移以及对放疗和化疗的敏感性。外泌体circRNAs有望成为诊断生物标志物和抗肿瘤靶点。在本文中,我们探讨了关于结直肠癌中外泌体circRNAs的最新研究,并描述了它们在结直肠癌发生发展中的生物学功能,阐明了它们作为生物标志物的潜力和靶向治疗能力。